HomeCompareSRTSF vs MRK

SRTSF vs MRK: Dividend Comparison 2026

SRTSF yields 2.26% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SRTSF wins by $16.11M in total portfolio value· pulled ahead in Year 2
10 years
SRTSF
SRTSF
● Live price
2.26%
Share price
$15.64
Annual div
$0.35
5Y div CAGR
88.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$16.17M
Annual income
$13,996,501.91
Full SRTSF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — SRTSF vs MRK

📍 SRTSF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSRTSFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SRTSF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SRTSF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SRTSF
Annual income on $10K today (after 15% tax)
$192.39/yr
After 10yr DRIP, annual income (after tax)
$11,897,026.62/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, SRTSF beats the other by $11,888,429.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SRTSF + MRK for your $10,000?

SRTSF: 50%MRK: 50%
100% MRK50/50100% SRTSF
Portfolio after 10yr
$8.11M
Annual income
$7,003,307.84/yr
Blended yield
86.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SRTSF
No analyst data
Altman Z
5.7
Piotroski
7/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SRTSF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSRTSFMRK
Forward yield2.26%2.81%
Annual dividend / share$0.35$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR88.3%32.7%
Portfolio after 10y$16.17M$57.7K
Annual income after 10y$13,996,501.91$10,113.78
Total dividends collected$15.97M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SRTSF vs MRK ($10,000, DRIP)

YearSRTSF PortfolioSRTSF Income/yrMRK PortfolioMRK Income/yrGap
1$11,126$426.20$11,213$373.04$87.00MRK
2← crossover$12,740$834.51$12,667$512.06+$73.00SRTSF
3$15,313$1,681.53$14,439$708.14+$874.00SRTSF
4$19,942$3,556.90$16,640$988.16+$3.3KSRTSF
5$29,489$8,151.62$19,432$1,394.07+$10.1KSRTSF
6$52,767$21,213.50$23,057$1,992.90+$29.7KSRTSF
7$123,261$66,800.21$27,889$2,894.79+$95.4KSRTSF
8$406,494$274,604.50$34,518$4,286.29+$372.0KSRTSF
9$2,028,634$1,593,686.32$43,912$6,494.35+$1.98MSRTSF
10$16,167,141$13,996,501.91$57,714$10,113.78+$16.11MSRTSF

SRTSF vs MRK: Complete Analysis 2026

SRTSFStock

Gr. Sarantis S.A., together with its subsidiaries, produces and trades in cosmetics, household products, and parapharmaceutical products. It operates through four segments: Mass Market Cosmetics, Household Products, Other Sales, and Private Label Products. The company provides personal care products, including baby care, baby wash, grooming, hair care, hair colorant, hair styling, hand wash, oral care, personal hygiene, shaving, skin care, and sun care products, as well as deodorants and fragrances; and home care products, such as dishwashing, drainer care, food packaging, insect control, and shoe care products, as well as bathroom cleaners, cleaning tools, septic tank activators, and garbage bags. It also offers health care products comprising food supplements, health and self-care products, and skin and sun care products; cosmetics, including candle, make up, treatment, and home and other fragrance products; and professional products, such as cleaning tools, detergents, and food and other packaging products. The company offers its products through hypermarkets, supermarkets, groceries, beauty shops, and pharmacies. It operates in Greece, Poland, Romania, Bulgaria, Serbia, the Czech Republic, Slovakia, Hungary, North Macedonia, Bosnia, Portugal, Ukraine, Russia, Cyprus, and France, as well as exports its products to approximately 50 countries in Europe, Asia, Africa, and Oceania. The company was founded in 1930 and is headquartered in Athens, Greece.

Full SRTSF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SRTSF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SRTSF vs SCHDSRTSF vs JEPISRTSF vs OSRTSF vs KOSRTSF vs MAINSRTSF vs JNJSRTSF vs ABBVSRTSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.